Antibiotics Market Analysis

Request Free Sample Copy

Report ID: 4465
Published Date: May 08, 2025
Report Format: PDF, PPT

Buy Now

Antibiotics Segmentation

Indication (Skin Infections, Respiratory, Gastrointestinal, UTIs, Blood Stream, Clostridium Difficile, Ear Infections)

The global antibiotics market is segmented and analyzed for demand and supply by indication into skin infections, respiratory, gastrointestinal, UTIs, blood stream, clostridium difficile, ear infections, and others. Out of these, the gastrointestinal segment is projected to significantly grow over the forecast period on the back of increasing prevalence of acute infectious diarrhea in children across the globe. For instance, acute infectious diarrhea is one of the most serious conditions in the world and is accountable for 1 million to 2.5 million deaths per year. Globally, more than 2 to 5 billion kids are affected every year.

Our in-depth analysis of the global market includes the following segments:

By Drug Class	Beta Lactam & Beta Lactamase Inhibitors Macrolide Others
By Drug Origin	Natural Semisynthetic Synthetic
By Spectrum of Activity	Broad-Spectrum Narrow-Spectrum Antibiotics
By Indication	Skin Infections Respiratory Gastrointestinal UTIs Blood Stream Clostridium Difficile Ear Infections Others
By End-User	Hospitals Specialty Clinics Others

Browse key industry insights with market data tables & charts from the report:

Antibiotics Market size to cross $144.25 billion by 2037 | 8.4% CAGR Forecast

Frequently Asked Questions (FAQ)

Antibiotics Market in 2025 is assessed at USD 53.95 billion.

The global market size was valued at over USD 50.55 billion in 2024 and is expected to expand at a CAGR of around 8.4%, surpassing USD 144.25 billion revenue by 2037.

Asia Pacific is forecast to exceed majority share by 2037, driven by growing prevalence of infectious diseases, increasing antibiotic consumption, and a rapidly growing population.

The major players in the market include F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Abbott Laboratories, Merck & Co., Inc., Lupin Limited, Melinta Therapeutics, LLC, Bayer AG.